Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divalent metal cation
- Molecular classification
- Other (ion), found as cofactors in enzymes, transporters, receptors, ion channels, transcription factors
01
Overview
Divalent metal cations are positively charged ions with a +2 valence state, including but not limited to magnesium (Mg²⁺), calcium (Ca²⁺), zinc (Zn²⁺), and manganese (Mn²⁺)[3][4][7]. They are crucial for numerous biological processes: serving as essential cofactors for enzymes, stabilizing the structure of macromolecules (such as DNA and proteins), and mediating cellular signaling, particularly in nervous and immune systems[1][4][6]. These ions are not themselves drug targets but are fundamental for the function of many cellular components that are[6][7]. Dysregulation can contribute to diseases, though therapeutic intervention usually targets specific proteins or pathways involving divalent cation homeostasis rather than the ions themselves[5].
- Other names
- Divalent cationmetal ion
02
Mechanism of action
Chelation (removal or sequestration of ions, e.g., EDTA, bisphosphonates); Supplementation or modulation of ion channels, influencing the cellular functions dependent on these cations.
03
Biological functions
Structural stabilization in macromolecules (DNA, RNA, proteins)Enzyme catalysis as cofactorsSignal transduction, e.g., Ca²⁺ in immune cell activationCell adhesion and migrationMetabolism regulation and glucose homeostasisRegulation of nervous system activity
04
Disease associations
Cancer (via enzyme regulation and chromatin effects)Cardiovascular disease (Ca²⁺/Mg²⁺ in muscle contraction)Neurodegenerative disease (Ca²⁺/Zn²⁺ dysregulation)Immunological disorders (immune cell signaling)Bone disease/defects (modulation of bone formation)Other, depending on specific ion involved
05
Safety considerations
Toxicity due to excess (e.g., hypercalcemia, hypermagnesemia, zinc poisoning)Deficiency syndromes (hypocalcemia, hypomagnesemia, zinc deficiency)Off-target effects when chelating agents are administered
Beyond the preview
Go deeper on Divalent metal cation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Divalent metal cation.